Literature DB >> 11794710

TNF and lymphotoxin-alpha polymorphisms in patients with severe chronic neutropenia.

N Gavrikova, C Zeidler, M Stanulla, M Germeshausen, B Schwinzer, K Welte.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794710     DOI: 10.1007/bf02982098

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product.

Authors:  A G Wilson; F S di Giovine; A I Blakemore; G W Duff
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

Review 2.  Severe chronic neutropenia: pathophysiology and therapy.

Authors:  K Welte; L A Boxer
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

3.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.

Authors:  C G Mullighan; G C Fanning; H M Chapel; K I Welsh
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

4.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.

Authors:  K Warzocha; P Ribeiro; J Bienvenu; P Roy; C Charlot; D Rigal; B Coiffier; G Salles
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

5.  Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.

Authors:  G Bouma; J B Crusius; M Oudkerk Pool; J J Kolkman; B M von Blomberg; P J Kostense; M J Giphart; G M Schreuder; S G Meuwissen; A S Peña
Journal:  Scand J Immunol       Date:  1996-04       Impact factor: 3.487

6.  Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.

Authors:  M A Bonilla; D Dale; C Zeidler; L Last; A Reiter; M Ruggeiro; M Davis; B Koci; W Hammond; A Gillio; Karl Welte
Journal:  Br J Haematol       Date:  1994-12       Impact factor: 6.998

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.